Intravenous immunoglobulin for severe sepsis and septic shock: clinical effectiveness, cost-effectiveness and value of a further randomised controlled trial

INTRODUCTION: Prior to investing in a large, multicentre randomised controlled trial (RCT), the National Institute for Health Research in the UK called for an evaluation of the feasibility and value for money of undertaking a trial on intravenous immunoglobulin (IVIG) as an adjuvant therapy for seve...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Crit Care
Main Authors: Soares, Marta O, Welton, Nicky J, Harrison, David A, Peura, Piia, Shankar-Hari, Manu, Harvey, Sheila E, Madan, Jason, Ades, Anthony E, Rowan, Kathryn M, Palmer, Stephen J
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2014
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4271457/
https://ncbi.nlm.nih.gov/pubmed/25434816
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13054-014-0649-z
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados